Organ-On-A-Chip Technology Expanding The Predictability Of In Vivo Testing
EMBRACING ORGAN-ON-A-CHIP (OOC) TECHNOLOGY: PHARMA'S CURRENT STATE
“Moving Away From Animal Models, The Industry Looks Towards OOC Technology”
For an inside look at the current state of OOC technology in drug development, download your free copy of “Moving Away From Animal Models, The Industry Looks Towards OOC Technology” from Citeline’s Scrip, presented in partnership with CN Bio.
Download the analysis from a recent pharmaceuticals industry study that reveals:
- Pharma’s overall drug development process concerns
- OOC adoption by the drug discovery industry, and reasons for not adopting OOC
- Current OOC usage by type and workflow
- Decision Factors and funding structures for OOC
- OOC Communication, collaboration, and education needs
